Table 1. Baseline Characteristics of FMP2.1/AS02A and Rabies Vaccine groups.
| Characteristics | FMP2.1/AS02A Half dose (n = 20) | FMP2.1/AS02A Full dose (n = 20) | Rabies Vaccine (n = 20) |
| Mean age in year (SD) | 26.1 (9.2) | 29 (11.2) | 30.1 (12.2) |
| Number of Females | 4 | 4 | 3 |
| Mean WBC×103/µL (SD) | 5.4 (1.3) | 5.9 (2.2) | 6.0 (1.5) |
| Mean hemoglobin g/dL (SD) | 14.4 (1.4) | 14.1 (1.6) | 14.0 (1.6) |
| Mean platelets×103/µL (SD) | 232.2 (61.3) | 252.3 (81.3) | 239.3 (68.2) |
| Mean lymphocytes×103/µL (SD) | 1.9 (0.6) | 2.3 (0.9) | 2.2 (0.8) |
| Mean creatinine mM/L (SD) | 77.8 (14.0) | 77.1 (18.6) | 76.6 (13.4) |
| Mean ALT U/L (SD) | 18.0 (6.6) | 17.3 (7.9) | 18.1 (5.7) |
| GMT Anti-AMA-1 antibody titer (95% CI) | 19,161 (8,570–42,844) | 23,500 (9,079–60,826) | 14,355 (5,860–35,165) |
GMT, geometric mean titer; CI, confidence interval; ALT, alanine amino-transferase; SD, standard deviation.